We are live on ! Find out more
BGMS

Bio Green Med Solution Inc

3 hedge funds and large institutions have $1.95M invested in Bio Green Med Solution Inc in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 33 (0)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% less ownership

Funds ownership: 0%0% (-0%)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

30% less capital invested

Capital invested by funds: $2.79M → $1.95M (-$838K)

Holders
3
Holders Change
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
1
Increased
1
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

BGMS Hedge Fund Activity: Q3 2017 in Review

3 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Bio Green Med Solution Inc (BGMS) for Q3 2017, worth a combined $1.95M — down 30% from $2.79M a quarter earlier.

Fund positioning in BGMS was balanced in Q3 2017: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Vanguard Group, adding an estimated $439K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $184K sold.

  • 3 institutional investors held Bio Green Med Solution Inc (BGMS) as of Q3 2017, unchanged from Q2 2017.
  • Funds reported $1.95M of Bio Green Med Solution Inc stock for Q3 2017, down 30% quarter-over-quarter.
  • 1 fund opened new Bio Green Med Solution Inc positions in Q3 2017 and 1 closed out, a net change of 0 holders.
  • The largest Bio Green Med Solution Inc buyer in Q3 2017 was Vanguard Group, an estimated $439K added.
  • The largest Bio Green Med Solution Inc seller in Q3 2017 was Renaissance Technologies, an estimated $184K sold.

Based on aggregated 13F filings for Q3 2017.